Page last updated: 2024-10-30

leflunomide and Respiratory Distress Syndrome

leflunomide has been researched along with Respiratory Distress Syndrome in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.

Research Excerpts

ExcerptRelevanceReference
"We present the case of a 62-year-old man with rheumatoid arthritis who developed a leukaemoid reaction and acute respiratory distress syndrome (ARDS) following granulocyte colony-stimulating factor (G-CSF) administration that had been given to treat neutropenia secondary to methotrexate and leflunomide toxicity."4.12Acute respiratory distress syndrome precipitated by granulocyte colony-stimulating factor in undiagnosed ( Chua, C; Cooke, R; Doig, C; Leung, T, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Doig, C1
Cooke, R1
Chua, C1
Leung, T1

Other Studies

1 other study available for leflunomide and Respiratory Distress Syndrome

ArticleYear
Acute respiratory distress syndrome precipitated by granulocyte colony-stimulating factor in undiagnosed
    BMJ case reports, 2022, Feb-03, Volume: 15, Issue:2

    Topics: Granulocyte Colony-Stimulating Factor; Humans; Leflunomide; Male; Methotrexate; Middle Aged; Neutrop

2022